Lankenau is the only hospital Pennsylvania to receive this distinction
(Wynnewood, PA, November 14, 2016) – For the tenth year, Lankenau Medical Center, part of Main Line Health’s Lankenau Heart Institute, has been named one of the nation’s 50 Top Cardiovascular Hospitals® by Truven Health Analytics in the “Top Teaching Hospitals with Cardiovascular Residency Programs” category. Lankenau is the only hospital in Pennsylvania to be named to the list.
“This award is emblematic of the continued excellence in cardiovascular care the Lankenau Heart Institute provides for our region,” said Phil Robinson, President, Lankenau Medical Center. “Our dedicated team of clinicians works collaboratively to provide, expert, patient-centered care, carefully personalized to meet the unique needs of the diverse patients we serve.”
Lankenau Medical Center is one of only five hospitals in the region able to perform transcatheter aortic valve replacement (TAVR), and is among the highest performing TAVR Centers in the nation. Currently Lankenau Medical Center is one of only two centers in the region participating in PARTNER 3, the first nation-wide randomized clinical study to address whether the benefits of TAVR also translate to patients at low risk for surgery.
Lankenau is also heavily involved in clinical research, and its cardiac surgeons have performed more than 1,500 robotic heart bypass procedures—more than any hospital in the nation. Lankenau Medical Center was recently named among Becker’s Hospital Review’s list of “100 Hospitals and Health Systems with Great Heart Programs.” U.S. News & World Report also recognized the hospital as high-performing for heart failure and heart bypass surgery in its common care ratings.
“Our expert clinical staff works collaboratively to provide the highest quality of cardiovascular care to our patients and this recognition reinforces our commitment to excellence,” says William Gray, MD, System Chief of Cardiology and President of Main Line Health’s Lankenau Heart Institute.
Truven’s study, now in its 18th year, uses a balanced national scorecard of hospital performance metrics to identify the 50 highest-performing cardiovascular services lines in the nation. The arduous processes used to calculate and measure hospital service lines leverage industry-leading, risk-adjusted methodologies, developed and maintained by Truven Health scientists over several years. These processes are widely regarded as the leading program for evaluating leadership impact in a hospital, as well as evaluating quality indicators and efficiencies.
Information about the study and other 100 Top Hospitals research is available at 100tophospitals.com. For information about cardiovascular services offered at Lankenau Medical Center and across Main Line Health, visit mainlinehealth.org/heart.
About Lankenau Medical Center
Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute for Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education, that trains over 100 new physicians each year through nationally ranked residency and fellowship programs. Lankenau has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Lankenau Medical Center has been named among the top 10 hospitals in Pennsylvania and top five in the Philadelphia metro area in U.S. News & World Report’s Best Hospitals 2016–2017, and was ranked as high-performing in four specialties: gastroenterology and GI surgery, geriatrics, orthopedics and pulmonology. Lankenau was also ranked as high performing in all nine of the Common Core specialty areas that the publication analyzes, including: abdominal aortic aneurysm repair, aortic valve surgery, COPD, colon cancer surgery, congestive heart failure, heart bypass surgery, hip replacement, knee replacement and lung cancer surgery. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation.
About the Lankenau Heart Institute
The Lankenau Heart Institute is Main Line Health System’s premier, comprehensive cardiovascular medicine and surgery program. The Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care Hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the System-wide coordination of services, the Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.